Reversal of monocrotaline-induced pulmonary hypertension by administration of endothelial progenitor cells (EPCs) transfected with endothelial NO synthase (eNOS)

被引：0
|
作者：
Zhao, YD [1 ]
Courtman, DW [1 ]
Deng, YP [1 ]
Zhang, QW [1 ]
Han, RN [1 ]
Trogadis, J [1 ]
Ng, D [1 ]
Stewart, DJ [1 ]
机构：
[1] St Michaels Hosp, Toronto, ON M5B 1W8, Canada
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1123
引用
收藏
页码：234 / 234
页数：1
相关论文
共 50 条
  • [21] Long-term inhibition of Rho-kinase markedly ameliorates monocrotaline-induced pulmonary hypertension and endothelial dysfunction in rats: effects on endothelial NO synthase
    Abe, K
    Uwatoku, T
    Oi, K
    Morikawa, K
    Hizume, T
    Shimokawa, H
    NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2004, 11 (01): : 58 - 59
  • [22] Reduced Endothelial Progenitor Cells (EPCs) in Patients with Severe Hypertension
    Zhu, Shoukang
    Deng, Shanming
    Yang, Falin
    Zhang, Taifang
    Afshartous, David
    Goldschmidt, Pascal J.
    Dong, Chunming
    Preston, Richard A.
    CIRCULATION, 2010, 122 (21)
  • [23] Resveratrol induced up-regulation of vascular endothelial growth factor in monocrotaline-induced pulmonary hypertension
    Lee, D
    Choi, S
    Kim, D
    Jung, Y
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 307A - 307A
  • [24] Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells - Efficacy of combined cell and eNOS gene therapy in established disease
    Zhao, YDD
    Courtman, DW
    Deng, YP
    Kugathasan, L
    Zhang, QW
    Stewart, DJ
    CIRCULATION RESEARCH, 2005, 96 (04) : 442 - 450
  • [25] Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting endothelial-to-mesenchymal transition
    Shi, Ruizan
    Zhu, Diying
    Wei, Zehui
    Fu, Naijie
    Wang, Chang
    Liu, Linhong
    Zhang, Huifeng
    Liang, Yueqin
    Xing, Jianfeng
    Wang, Xuening
    Wang, Yan
    LIFE SCIENCES, 2018, 207 : 442 - 450
  • [26] Intravenous administration of mesenchymal stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats
    Nagaya, N
    Fuji, T
    Iwase, T
    Itch, T
    Murakami, S
    Mori, H
    CIRCULATION, 2004, 110 (17) : 234 - 234
  • [27] PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension
    Liao, Juan
    Xie, Shan -Shan
    Deng, Yan
    Wu, Dan-dan
    Meng, Hui
    Lan, Wei-fan
    Dai, Ping
    MICROVASCULAR RESEARCH, 2023, 146
  • [28] Mesenchymal stem cells attenuate monocrotaline-induced pulmonary hypertension
    Kadowitz, PJ
    Baber, S
    Hyman, AL
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2005, 38 (05) : 871 - 871
  • [29] Oxidative stress mediates monocrotaline-induced alterations in tenascin expression in pulmonary artery endothelial cells
    Aziz, SM
    Toborek, M
    Hennig, B
    Mattson, MP
    Guo, HT
    Lipke, DW
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (05): : 775 - 787
  • [30] Monocrotaline-Induced Pulmonary Hypertension Involves Downregulation of Antiaging Protein Klotho and eNOS Activity
    Varshney, Rohan
    Ali, Quaisar
    Wu, Chengxiang
    Sun, Zhongjie
    HYPERTENSION, 2016, 68 (05) : 1255 - 1263
12345